Research Articleposted 2024-11-15 11:38:19
A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001)
Gaowa Jin, Yi-Long Wu, Qing Zhou, Chong-Rui Xu, Yan Yu, Ying Cheng, Shubin Tang, and 11 more authors
Published
at
Short Reportposted 2024-11-08 15:43:11
Spatial Imaging Unlocks the Potential of Charting Multiple Myeloma and Extramedullary Disease
Vanessa Desantis, Alessandro Andriano, Tim Düking, Olga Hartwig, Giuseppe Ingravallo, Roberto Ria, Angelo Vacca, and 1 more authors
Published
at
Research Articleposted 2024-10-02 18:11:10
Hypomagnesemia in Large B cell Lymphoma patients receiving CAR T cell therapy correlates with immune dysregulation and decreased PFS: results from the ZUMA-1 trial and Mayo Clinic cohort
Januario E. Castro, Jonas Paludo, Jose C. Villasboas-Bisneto, Arushi Khurana, Urshila Durani, Yucai Wang, Paul J. Hampel, and 31 more authors
Under Review
at
Research Articleposted 2023-03-09 15:39:23
Novel Scheme for Defining the Clinical Implications of TP53 Mutations in Myeloid Neoplasia
Yazan Madanat, Jaroslaw P. Maciejewski, Valeria Visconte, Torsten Haferlach, Manja Meggendorfer, Minako Mori, Ramsha Ahmed, and 12 more authors
Published
at
Research Articleposted 2022-09-13 15:08:39
Tumor Cell Integrin β4 and Tumor Stroma E-/P-Selectin Cooperatively Regulate Tumor Growth in vivo
Gerrit Wolters-Eisfeld, Tobias Lange, Udo Schumacher, Manfred Jücker, Stefan Linder, Linda Diehl, Katrin Lamszus, and 21 more authors
Published
at
Research Articleposted 2022-05-11 17:29:09
Elraglusib (9-ING-41), a selective small molecule inhibitor of Glycogen Synthase Kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3, and enhances CD8+ T cell cytolytic killing of melanoma cells.
Gary Shaw, Ludimila Cavalcante, Francis Giles, Alison Taylor
Under Review
at
Research Articleposted 2022-05-03 17:28:32
Olverembatinib (HQP1351), a highly safe and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial
Yang Liang, Xiaojun Huang, Dajun Yang, Yifan Zhai, Ming Lu, Hengbang Wang, Qian Niu, and 16 more authors
Under Review
at
correspondenceposted 2022-05-03 14:21:25
Evidence of SARS-CoV-2 Spike protein on retrieved thrombi from COVID-19 patients
Manuela De Michele, Giulia d'Amati, Martina Leopizzi, Marta Iacobucci, Irene Berto, Svetlana Lorenzano, Laura Mazzuti, and 3 more authors
Under Review
at
Research Articleposted 2022-04-21 16:24:34
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and COVID-19: A study of ERIC, the European Research Initiative on CLL
Darko Antic, Natasa Milic, Thomas Chatzikonstantinou, Lydia Scarfò, Vladimir Otasevic, Nina Rajovic, David Allsup, and 54 more authors
Under Review
at
Research Articleposted 2021-06-22 15:08:27
Prognostic and Therapeutic Biomarker Developments in Multiple Myeloma
Craig Thomas Wallington-Beddoe, Rachel Lauris Mynott
Under Review
at